Home » FDA Clears CorticoMetrics’ Quantitative AI Solution for Brain MRIs
FDA Clears CorticoMetrics’ Quantitative AI Solution for Brain MRIs
CorticoMetrics has received FDA 510(k) marketing clearance for THINQ, artificial intelligence-based software that conducts volumetric measurements and visualizations of the brain.
The software automatically segments a magnetic resonance imaging (MRI) brain image, assembling a report of volumetric measurements and visualizations of 30 important brain structures. It is designed to help improve the assessment of a number of neurological disorders and conditions.
THINQ provides quantitative reports that include brain images with color-coded segmentations and visual plots that show how the measurements compare with reference data.
Upcoming Events
-
07May
-
14May
-
30May